Clinical Trial Update: Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium

View source ↗

Summary

A Belgian real-world study reports patient-reported outcomes for benralizumab in adults with severe eosinophilic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: COMPLETED